Dialyzable Leukocyte Extract (DLE) is a biological substance derived from leukocytes, which are white blood cells that play a crucial role in the body's immune response. DLE is obtained through a process called dialysis, where the soluble components of leukocytes are separated from the insoluble components.
DLE is composed of various molecules such as cytokines, peptides, and other bioactive substances that are important for immune regulation and modulation. These molecules are believed to have the ability to enhance and balance the immune response in the body.
The extract's dialyzable nature allows it to be easily absorbed and utilized by the human body. It can be administered orally, sublingually, or via injection. DLE is often used as a natural immunomodulatory therapy to boost the immune system in individuals with weakened or compromised immune function.
It is believed that DLE helps in restoring the balance and functionality of the immune system by promoting the production and activation of immune cells, enhancing their communication and coordination, and modulating the release of various immune mediators.
DLE has been used in the treatment of various conditions such as allergies, autoimmune diseases, viral infections, and cancer. Clinical studies have suggested its potential efficacy in improving immune system functions and reducing symptoms associated with these conditions.
However, further research is still needed to fully understand the mechanisms of action and therapeutic applications of DLE.
